Why Elan Is Inviting Royalty Pharma Bid

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 17 (Bloomberg) -- Elan Corp. is seeking a buyer and will invite Royalty Pharma, whose $6.7 billion bid it rejected, to participate, suggesting the two companies may end a standoff that has lasted almost four months. Jonathan Ferro reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change